About this trial
The purpose of this study is to evaluate the standard of care practices, procedural outcomes, and in-hospital complications for endovascular peripheral interventions of femoral, popliteal and infrapopliteal lesions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subject ≥18 years old
Subject has provided written informed consent
Subject has Rutherford classification 2 to 6
Reference vessel diameter ≥2 and ≤7 mm
Disqualifiers
Subject has a single target lesion that involves both ATK and BTK segments.
Subject not suitable for receiving endovascular procedures of lower limb arteries.
Prior planned major amputation in the target limb (i.e., above the ankle).
Subject with previous bypass surgery of target vessel.
Trial population
A total of 200 patients will be enrolled, with approximately 100 subjects in ATK group, and 100 subjects in BTK group.
Trial design
Cohort
Prospective
Treatments tested in this trial
Oscar Peripheral Multifunctional Catheter
DeviceOscar Peripheral Multifunctional Catheter encompasses three components: (i) Oscar Support Catheter with integrated Lock Grip, (ii) Oscar Dilator and (iii) Oscar PTA Balloon. Single Oscar PTA Balloon is also available separately and can only be used together with the pre-supplied Oscar Support Catheter as indicated in the compatibility chart in the Instructions for Use (IFU).
Treatment groups
Trial outcomes
Primary outcomes
Oscar Procedural success rate
combination of Oscar technical success and absence of serious procedural complications
Secondary outcomes
Rate of (Serious) Adverse Device Effects (S)ADE
(Serious) Adverse Device Effects
Rate of distal embolization
Distal embolization
Rate of target vessel rupture
Target vessel rupture
Rate of target vessel perforation
Target vessel perforation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.